RxDoctor Payments Data

Jessica Demay

Maternal & Fetal Medicine · Richmond, VANPI 1093708281

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.7% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $371 and has fallen 55.2% since, to $166 in 2025.

$1,377in general payments, 2019–2025

Across 82 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$266
  • Mayne Pharma Commercial LLC$197
  • Bayer$121
  • Biogen$116
  • Novo Nordisk$67
  • Urovant Sciences Inc$67
  • plus $543 from 19 others

What the payments were for

  • Food & beverage$1,34698%
  • Education$312%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,377 in reported general payments places this provider in the 80th percentile of 52 maternal & fetal medicine providers in Virginia.

See all maternal & fetal medicine providers in Virginia

Other maternal & fetal medicine in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →